An international team has reported findings from an independent assessment of five commercially available ctDNA assays as a method to […]
Liquid biopsy has the promise to revolutionise cancer care and treatment, allowing the detection of rare cell types with a […]
Researchers find that cell-free circulating tumour DNA (ctDNA) analyses before and during treatment could help guide selection of therapy for […]
A recent review, published in Cancers, has summarised the current landscape of ctDNA analysis in clinical practice as well as […]
Researchers have validated the use of circulating tumour DNA (ctDNA) and metabolites in cerebrospinal fluid (CSF) as potential biomarkers for […]
The advantages of non-invasive cancer testing are well known, yet routine clinical implementation is still a long way off. Despite […]
Front Line Genomics is pleased to announce the first Tri-Omics Summit in Boston, MA on 27th – 29th September 2022. […]
Check out the latest Genomics Week in Brief – full of intriguing news and research from the genomics space! Top […]
Join us for Liquid Biopsy ONLINE, a 3 part webinar series, where we explore the technologies behind liquid biopsies, their […]
Written by Poppy Jayne Morgan A new study in ESMO Open has identified a faster and more accurate diagnosing tool […]
